METTL3 can promotes osteogenic differentiation of human aortic valve interstitial cells by inhibiting TWIST1 expression through an m6A-dependent pathway, aggravating valve calcification and leading to the development of valvular heart disease. The gene discussed is METTL3; the disease is heart valve disorder.